Print  |  Close

A Phase II Study of CAR T-ddBCMA for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma


Active: Yes
Cancer Type: Multiple Myeloma NCT ID: 05396885
Trial Phases: Phase II Protocol IDs:
Eligibility: , Male and Female Study Type:
Study Sponsor:
NCI Full Details:

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.